CPRX
Catalyst Pharmaceuticals Inc
Price:  
21.97 
USD
Volume:  
660,354.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

CPRX WACC - Weighted Average Cost of Capital

The WACC of Catalyst Pharmaceuticals Inc (CPRX) is 8.7%.

The Cost of Equity of Catalyst Pharmaceuticals Inc (CPRX) is 13.95%.
The Cost of Debt of Catalyst Pharmaceuticals Inc (CPRX) is 4.50%.

Range Selected
Cost of equity 12.00% - 15.90% 13.95%
Tax rate 22.90% - 24.70% 23.80%
Cost of debt 4.50% - 4.50% 4.50%
WACC 7.7% - 9.7% 8.7%
WACC

CPRX WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 1.78 1.97
Additional risk adjustments 0.0% 0.5%
Cost of equity 12.00% 15.90%
Tax rate 22.90% 24.70%
Debt/Equity ratio 1 1
Cost of debt 4.50% 4.50%
After-tax WACC 7.7% 9.7%
Selected WACC 8.7%